New York, NY -- (SBWIRE) -- 12/30/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Amarin Corporation plc (ADR)(NASDAQ:AMRN)Huntington Bancshares Incorporated(NASDAQ:HBAN), Mast Therapeutics Inc(NYSEMKT:MSTX), Organovo Holdings Inc(NYSEMKT:ONVO)
Amarin Corporation plc (ADR)(NASDAQ:AMRN) settled 2.67% lower at $1.82 on below -normal volume of 3.43M shares during the last trading day. The stock has its 12-month high at $9.24 and 52-week low price was $1.36. It traded in a range of $1.80 to $1.90 during the last trading day.Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases.
Can Investors Bet on AMRN after this News update? Find out in this Research Report
In the last trading session, Huntington Bancshares Incorporated(NASDAQ:HBAN) was downon low volume, trading at a volume of 3.42 million versus its average daily volume of 8.58million shares. At $9.61, the stock has attained market capitalization of $7.98billion whereas its outstanding shares are 830.52 million.Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services.
How Should Investors Trade HBAN Now? Don’t Miss out a Special Trend Analysis
Mast Therapeutics Inc(NYSEMKT:MSTX) managed to keep its fall at 0.99% on above-normal volume of 3.35M shares. The stock settled at $0.442 after floating in a range of $0.44 to $0.46. At its latest price, the stock reached market capitalization of $45.36million. Its 52-week range has been $0.40to $1.81.Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases.
How Should Investors Trade MSTX Now? Don’t Miss out a Special Trend Analysis
Organovo Holdings Inc(NYSEMKT:ONVO) traded up on a volume of 3.32 million, lower than its standard daily volume. Shares have gained 2.52% to $9.25. Over the last twelve months, the stock has gained 248.87% and faced a worst price of $2.35.Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications.
Is GDX a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)